Tuesday, August 01, 2017 11:00:13 PM
This is the entry on FDA Calendar
This is still a strong stock with 2 catalyst's due by 12/31/2017 and 1 "later this year" with 1 more in 2Q 2018. All upcoming catalysts are either Phase 2 or 2a
They may or may not have mis-calculated with the RS, however I still believe that RNN will come good. It has hit oversold territory and also seems to have found it's bottom. If the Archexin news is good, then it will rocket back up again, given that two of the other three catalysts are due by the end of 2017.
GO $RNN
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM